These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23601908)

  • 1. [Use of drug reimbursement as markers of disease for epidemiological and cost analysis: The case of severe epilepsy in France].
    Fagnani F; Vespignani H; Kusnik-Joinville O; Bertrand M; Murat C; Lévy-Bachelot L; Kahane P
    Presse Med; 2013 Sep; 42(9 Pt 1):e285-92. PubMed ID: 23601908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL; Candrilli SD; Edin HM
    Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of focal epilepsy in adults treated with polytherapy in France: the direct cost of drug resistance (ESPERA study).
    de Zélicourt M; de Toffol B; Vespignani H; Laurendeau C; Lévy-Bachelot L; Murat C; Fagnani F
    Seizure; 2014 May; 23(5):349-56. PubMed ID: 24560531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy.
    Ettinger AB; Manjunath R; Candrilli SD; Davis KL
    Epilepsy Behav; 2009 Feb; 14(2):324-9. PubMed ID: 19028602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany.
    Strzelczyk A; Haag A; Reese JP; Nickolay T; Oertel WH; Dodel R; Knake S; Rosenow F; Hamer HM
    Epilepsy Behav; 2013 Jun; 27(3):433-8. PubMed ID: 23591262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of reimbursement restrictions on the choice of antiepileptic drugs: Belgian Study on Epilepsy Treatment (BESET).
    Boon P; Dejonghe P; Legros B; Sadzot B; van Rijckevorsel K; Schmedding E
    Seizure; 2008 Jun; 17(4):350-7. PubMed ID: 18203628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of antiepileptic pharmacotherapy in a tertiary referral center in South India: a pharmacoepidemiologic and pharmacoeconomic study.
    Radhakrishnan K; Nayak SD; Kumar SP; Sarma PS
    Epilepsia; 1999 Feb; 40(2):179-85. PubMed ID: 9952264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview.
    Willems LM; Richter S; Watermann N; Bauer S; Klein KM; Reese JP; Schöffski O; Hamer HM; Knake S; Rosenow F; Strzelczyk A
    Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.
    Italiano D; Capuano A; Alibrandi A; Ferrara R; Cannata A; Trifirò G; Sultana J; Ferrajolo C; Tari M; Tari DU; Perrotta M; Pagliaro C; Rafaniello C; Spina E; Arcoraci V
    Br J Clin Pharmacol; 2015 Jun; 79(6):1010-9. PubMed ID: 25556909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Payer costs of patients diagnosed with epilepsy.
    Griffiths RI; Schrammel PN; Morris GL; Wills SH; Labiner DM; Strauss MJ
    Epilepsia; 1999 Mar; 40(3):351-8. PubMed ID: 10080518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy.
    Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS
    Epilepsy Behav; 2014 Feb; 31():356-62. PubMed ID: 24239435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of socio-economic factors causing discontinuation of epilepsy treatment resulting in seizure recurrence: a study in an urban epilepsy clinic in India.
    Das K; Banerjee M; Mondal GP; Devi LG; Singh OP; Mukherjee BB
    Seizure; 2007 Oct; 16(7):601-7. PubMed ID: 17576079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population.
    Landmark CJ; Fossmark H; Larsson PG; Rytter E; Johannessen SI
    Epilepsy Res; 2011 Jun; 95(1-2):51-9. PubMed ID: 21435840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic aspects of drug-resistant epilepsy].
    Owczarek K; Jedrzejczak J
    Neurol Neurochir Pol; 2001; 35(2):309-18. PubMed ID: 11599228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epilepsy in adults: a costs-of-illness study].
    Vlasov PK; Orekhova NV; Filatova NV; Leonova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):44-7. PubMed ID: 20873473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure clusters, treatment patterns, and healthcare resource utilization in patients with epilepsy: A Wisconsin-based claims analysis.
    Morris GL; Eads P; Tryfon M; Ems D
    Epilepsy Behav; 2024 Aug; 157():109867. PubMed ID: 38824751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-care costs and utilization related to long- or short-acting antiepileptic monotherapy use.
    Cramer JA; Wang ZJ; Chang E; Copher R; Cherepanov D; Broder MS
    Epilepsy Behav; 2015 Mar; 44():40-6. PubMed ID: 25635369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States.
    Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S
    Epilepsia; 2010 May; 51(5):838-44. PubMed ID: 20002150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of epilepsy care in a Nigerian tertiary hospital.
    Sanya EO; Kolo PM; Adekeye A; Mustapha K; Ademiluyi BA; Ajayi K
    Niger Postgrad Med J; 2013 Sep; 20(3):218-22. PubMed ID: 24287754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany.
    Strzelczyk A; Bergmann A; Biermann V; Braune S; Dieterle L; Forth B; Kortland LM; Lang M; Peckmann T; Schöffski O; Sigel KO; Rosenow F
    Epilepsy Behav; 2016 Nov; 64(Pt A):75-82. PubMed ID: 27732920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.